Literature DB >> 15033387

Relative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and beta-adrenergic renal vasodilations.

Mahmoud M El-Mas1, Mahmoud M Mohy El-Din, Sahar M El-Gowilly, Fouad M Sharabi.   

Abstract

Vascular toxicity is a major adverse effect for the immunosuppressant drug cyclosporine A. The present study sought to characterize the relative roles of the endothelium-derived relaxing factors (nitric oxide, endothelium-derived hyperpolarizing factor [EDHF], and prostaglandins) in the cyclosporine-induced impairment of renovascular responsiveness to acetylcholine receptor or beta-adrenoceptor activation. Changes evoked by cyclosporine in the responses to either vasorelaxant were evaluated in phenylephrine-preconstricted isolated perfused rat kidneys in the absence and presence of N(G)-nitro-l-arginine methyl ester (l-NAME, nitric oxide synthase inhibitor), tetraethylammonium (K(+) channel blocker), or diclophenac (cyclooxygenase inhibitor). Acetylcholine (0.03-2 nmol) vasodilations were significantly inhibited by prior treatment with l-NAME, tetraethylammonium, or diclophenac, suggesting a role for nitric oxide, EDHF, and prostaglandins in acetylcholine vasodilations. Isoprenaline (0.125-4 micromol) vasodilations were inhibited by l-NAME and tetraethylammonium versus no effect for diclophenac. Cyclosporine (1-4 microM) produced a concentration-related inhibition of vasodilations relaxations produced by either vasodilator. Cyclosporine-induced inhibition of acetylcholine vasodilations was attenuated in tissues pretreated with l-NAME or tetraethylammonium but not diclophenac, implicating nitric oxide and EDHF in cyclosporine-acetylcholine interaction. On the other hand, the inhibition of isoprenaline vasodilations by cyclosporine was virtually abolished by l-NAME. In cyclosporine-treated kidneys, exposure to l-arginine, the substrate of nitric oxide synthesis, fully restored isoprenaline vasodilations to control levels and significantly increased acetylcholine vasodilations. It is concluded that the identity and relative contributions of endothelial factors to renal vasodilatory responses as well as to the inhibition of these responses by cyclosporine largely depend on the vasodilator stimulus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15033387     DOI: 10.1016/j.ejphar.2004.01.025

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

Review 1.  Central modulation of cyclosporine-induced hypertension.

Authors:  Hanan M El-Gowelli; Mahmoud M El-Mas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-11-29       Impact factor: 3.000

2.  A role for cyclooxygenase in aging-related changes of beta-adrenoceptor-mediated relaxation in rat aortas.

Authors:  Khong Bee Kang; M A Sharmini Rajanayagam; Andrea van der Zypp; Henryk Majewski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-04-03       Impact factor: 3.000

3.  Pioglitazone abrogates cyclosporine-evoked hypertension via rectifying abnormalities in vascular endothelial function.

Authors:  Mahmoud M El-Mas; Hanan M El-Gowelli; Khaled S Abd-Elrahman; Evan I Saad; Abdel-Galil A Abdel-Galil; Abdel A Abdel-Rahman
Journal:  Biochem Pharmacol       Date:  2010-11-27       Impact factor: 5.858

4.  Endothelin ETA receptor/lipid peroxides/COX-2/TGF-β1 signalling underlies aggravated nephrotoxicity caused by cyclosporine plus indomethacin in rats.

Authors:  Maged W Helmy; Hanan M El-Gowelli; Rabab M Ali; Mahmoud M El-Mas
Journal:  Br J Pharmacol       Date:  2015-07-30       Impact factor: 8.739

5.  Effects of Chrysophyllum albidum fruit pulp on haemodynamic parameters, pro-inflammatory markers, antioxidant parameters and critical biomolecules associated with hypertension-in vivo.

Authors:  Folake Lucy Oyetayo; Seun Funmilola Akomolafe; Gbemisola Beulah Balogun
Journal:  Inflammopharmacology       Date:  2021-06-12       Impact factor: 4.473

6.  The influence of perfusion solution on renal graft viability assessment.

Authors:  Colin H Wilson; Hugh Wyrley-Birch; Dhakshinarmoorthy Vijayanand; Anabelle Leea; Noel M Carter; Malcolm Haswell; Anne C Cunningham; David Talbot
Journal:  Transplant Res       Date:  2012-10-18

7.  Interference with AGEs formation and AGEs-induced vascular injury mediates curcumin vascular protection in metabolic syndrome.

Authors:  Osama A A Ahmed; Hany M El-Bassossy; Ahmad S Azhar; Mayada M Tarkhan; Mahmoud M El-Mas
Journal:  Sci Rep       Date:  2020-01-15       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.